ALCOX:EPA
NicOx SA
€ ०.३०
arrow_downward
-१.२९%(-०.००४०) 1D
अक्टोबर १२, १२:११:०९ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३०
Mkt. cap
२.९७ करोड
Avg. vol.
१.६५ लाख
Volume
५६.३४ हजार
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३०
Mkt. cap
२.९७ करोड
Avg. vol.
१.६५ लाख
Volume
५६.३४ हजार
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
News stories
From web sources and news partners
marketscreener.com
·
१३ मिनेट पहिले
Goldman Sachs Adjusts Price Target on Dow to $31 From $33
Yahoo Finance
·
२३ मिनेट पहिले
2 S&P 500 Stocks to Own for Decades and 1 We Ignore
Sahi
·
१ घण्टा पहिले
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
Stocktwits
·
१० घण्टा पहिले
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees१०
Founded१९९६
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, फ्रान्स
Sector-
Websitenicox.com